Ishwaria Subbiah: FTC Announces Rule Banning Non-competes
- Calls out protections for physicians by name
- Rule takes effect for all workers starting 120 days from when this rule is published in the Federal Register
- After day 120, no new non-competes for all. Existing non-competes will be unenforceable for most workers (except seniors execs earning ~>$151K/yr in a policy-making role – i.e. not most physicians).”
Ishwaria Subbiah is the Executive Director for Cancer Care Equity and Professional Wellness at Sarah Cannon Research Institute (SCRI). In this role, Dr. Subbiah focuses on reducing cancer outcomes disparities and diversifying clinical trial participation within SCRI’s combined research network of over more than 1,300 physicians at over 250 locations in 24 states across the US.
Dr. Subbiah is a globally recognized expert in geriatric oncology, symptom management, palliative care, and healthcare professional well-being. She previously was an associate professor in the Division of Cancer Medicine at the University of Texas MD Anderson Cancer Center.
She is the Chair for the ASCO Women in Oncology working group and the ASCO State of Cancer Care in America initiative.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023